Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
This study has been completed.
Study NCT00543400 Information provided by Momenta Pharmaceuticals, Inc.
First Received on October 11, 2007. Last Updated on April 30, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease (CAD)
Additional conditions recognized in this trial
Coronary Artery Disease
More general conditions related to this trial
Arterial Occlusive Diseases
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Momenta Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers